First NICE-recommended treatment for chronic heart failure
European Pharmaceutical Review
MAY 19, 2023
Final draft guidance has been published for the first National Institute for Health and Care Excellence (NICE)-recommended treatment for symptomatic chronic heart failure with preserved or mildly reduced ejection fraction. The study enrolled 6,263 randomised patients. This was reported as 16.4 percent in the dapagliflozin group and 19.5
Let's personalize your content